Comparison of pharmacokinetic profiles of a 17β-estradiol gel 0.6 mg/g (Gelestra) with a transdermal delivery system (Estraderm TTS 50) in postmenopausal women at steady state

This publication has 20 references indexed in Scilit:

• Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
  JAMA, 1998
• Efficacy and tolerability of Menorest® 50 compared with estraderm® TTS 50 in the treatment of postmenopausal symptoms. A randomized, multicenter, parallel group study
  Maturitas, 1995
• Comparative endocrinological and clinical effects of percutaneous estradiol and oral conjugated estrogens as replacement therapy in menopausal women
  Maturitas, 1991
• Neuroendocrine and clinical effects of transdermal 17β-estradiol in postmenopausal women
  Maturitas, 1991
• Adverse skin reactions to transdermal oestradiol in tropical climate. A comparative study of skin tolerance after using oestradiol patch and gel in Thai postmenopausal women
  Maturitas, 1991
• Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
• Estrogen Therapy During Menopause
  Drugs, 1990
• A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability
  Journal of Pharmacokinetics and Biopharmaceutics, 1987
• Hip Fracture and the Use of Estrogens in Postmenopausal Women
  New England Journal of Medicine, 1987
• Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of Estrogen
  New England Journal of Medicine, 1980